Interventions for structural heart disease

Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve

EuroIntervention 2015;11:343-350 published online ahead of print November 2014. DOI: 10.4244/EIJY14M11_06

Giuseppe Tarantini*, MD, PhD; Marco Mojoli, MD; Paola Purita, MD; Massimo Napodano, MD; Augusto D’Onofrio, MD, PhD; Annachiara Frigo, MSc; Elisa Covolo, MD; Michela Facchin, MD; Giambattista Isabella, MD; Gino Gerosa, MD; Sabino Iliceto, MD, FACC, FESC

Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padua, Italy

Aims: Early data on the Edwards SAPIEN 3 valve (S3-THV) have shown low rates of paravalvular leaks and vascular complications but relatively high 30-day permanent pacemaker implantation (

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic valve diseasepacemakertavivalvuloplasty

Share on Facebook Share on Twitter Share on Linkedin